Skip to main content

Advertisement

Log in

The Regulation of Microglial Cell Polarization in the Tumor Microenvironment: A New Potential Strategy for Auxiliary Treatment of Glioma—A Review

  • Review Paper
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Glioma is the most common primary tumor of the central nervous system and normally should be treated by synthetic therapy, mainly with surgical operation assisted by radiotherapy and chemotherapy; however, the therapeutic effect has not been satisfactory, and the 5-year survival rates of anaplastic glioma and glioblastoma are 29.7% and 5.5%, respectively. To identify a more efficient strategy to treat glioma, in recent years, the influence of the inflammatory microenvironment on the progression of glioma has been studied. Various immunophenotypes exist in microglial cells, each of which has a different functional property. In this review, references about the phenotypic conversion of microglial cell polarity in the microenvironment were briefly summarized, and the differences in polarized state and function, their influences on glioma progression under different physiological and pathological conditions, and the interactive effects between the two were mainly discussed. Certain signaling molecules and regulatory pathways involved in the microglial cell polarization process were investigated, and the feasibility of targeted regulation of microglial cell conversion to an antitumor phenotype was analyzed to provide new clues for the efficient auxiliary treatment of neural glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

Not applicable.

Abbreviations

CNS:

Central nervous system

GBM:

Glioblastoma

TBI:

Traumatic brain injury

iNOS:

Inducible nitric oxide synthase

IFNγ:

Interferon-γ

IL-1β:

Interleukin-1β

IL-6:

Interleukin-6

IL-12:

Interleukin-12

TNF:

Tumor necrosis factor

AD:

Alzheimer disease

PD:

Parkinson disease

arg-1:

Arginase-1

IGF-1:

Insulin-like growth factor 1

IL-4:

Interleukin-4

IL-13:

Interleukin-13

IL-10:

Interleukin-10

TGF-β:

Transforming growth factor-β

VEGF:

Vascular endothelial growth factor

BDNF:

Brain-derived neurotrophic factor

IL-18:

Interleukin-18

IL-23:

Interleukin-23

ROS:

Reactive oxygen species

ALS:

Amyotrophic lateral sclerosis

NADPH:

Nicotinamide adenine dinucleotide phosphate

IDH:

Isocitrate dehydrogenase

GM-CSF:

Granulocyte macrophage colony stimulating factor

MMP:

Matrix metalloproteinase

BBB:

Blood–brain barrier

GSLCs:

Glioma stem-like cells

PPARγ:

Peroxisome proliferator-activated receptor γ

K-ATP:

ATP-sensitive potassium

SAH:

Subarachnoid hemorrhage

ROS:

Reactive oxygen species

CSF-1:

Colony stimulating factor 1

Dul:

Duloxetine

PRC 2:

Polycomb repressive complexes 2

References

Download references

Acknowledgements

The authors thank Wang Jiaxi for critical review of the manuscript.

Funding

This work was supported by the Natural Science Foundation of Hebei Province (Grant Number H2020206322).

Author information

Authors and Affiliations

Authors

Contributions

LZ researched the literature and drafted the manuscript. DX and YH critically reviewed and edited the work. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yu-Hua Hu.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, L., Xu, DG. & Hu, YH. The Regulation of Microglial Cell Polarization in the Tumor Microenvironment: A New Potential Strategy for Auxiliary Treatment of Glioma—A Review. Cell Mol Neurobiol 43, 193–204 (2023). https://doi.org/10.1007/s10571-022-01195-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-022-01195-7

Keywords

Navigation